A gift to the Department of Surgery helps our physicians and scientists find new treatments and cures for serious diseases.
Maurice Galante, M.D., a legendary master surgeon at UCSF and renaissance man, died on February 5, 2013. His career is memorialized by the Maurice Galante Lecture Program and Maurice Galante Distinguished Professorship.
Dr. Stanley Rogers is associate clinical professor of surgery, and chief of the Section of Minimally Invasive Surgery in the Division of General Surgery at the University of California, San Francisco. He received a BA in zoology and physiology from the University of Wyoming and an MD from the University of Utah School of Medicine. Dr. Rogers completed his surgical training at UCSF, including his general surgery residency, as well as fellowships in laparoscopic surgery, surgical sonography and GI endoscopy. His research interests are in the areas of liver tumor ablation and GI and bariatric surgery in particular studying minimally invasive surgery .
Dr. Rogers is also director of the Bariatric Surgery Center at UCSF Medical Center, co-director of Videoendoscopic Surgery at San Francisco General Hospital, and a member of the clinical team at the UCSF Helen Diller Family Comprehensive Cancer Center.
In 2012, Dr. Rogers was selected as one of 15 surgeons in the UCSF Department of Surgery to be named as one of America's Top Doctors. This list, prepared by U.S. News & World Report in collaboration with Castle Connolly Medical Ltd., is compiled from a peer nomination process, and recognizes physicians deemed to be among the top 1% in the nation in his or her specialty.
A recent
study in the New England Journal of Medicine touts a new
medical device for the treatment of
Gastroesophageal Reflux Disease (GERD) as an alternative
to standard therapy, long-term proton-pump inhibitors or
Nissen Fundoplication. The
new treatment is a surgical procedure in which a small band of
magnetic beads is surgically implanted to augment the lower esophageal
sphincter, the valve
between the esophagus and stomach.
But Stanley J. Rogers, M.D., Associate Professor of Surgery at UCSF, Chief of Minimally Invasive Surgery, and Chief of Bariatric Surgery, expressed concern about its use, telling CBS/KCBS News Healthwatch that the device was essentially untested except for the small study cited above. He cautioned that the beads were a foreign object and where the device was placed could potentially cause serious complications including infection, perforation and abdominal sepsis, leading to ultimate removal. He emphasized that long-term data was needed to demonstrate its safety and effectiveness.
HealthWatch: GERD Necklace Could Be Answer To Acid Reflux (Dr. Rogers Interview)
In its most recent survey, U.S. News named Stanley J. Rogers, M.D. to its list of U.S. News "Top Doctors". Rogers was also named to the prestigious America's Top Doctors (ATD) list, a distinction reserved for the top 1% of physicians in the nation for that specialty. The listings are published online at U.S. News.
UCSF has been accredited by the American
College of Surgeons (ACS) as a Level 1
Accredited Bariatric Center (ACS BSCN). The American College of
Surgeons Bariatric Surgery Center Network Accreditation Program
(ACS BSCN) accredits facilities in the United States that have
undergone an independent, voluntary and rigorous peer evaluation in
accordance with nationally recognized bariatric surgical
standards. This adds to the prestige of the program which
previously also earned the Blue Distinction for
Bariatric Surgery from Blue Shield of California
and was designated a Blue Cross "Center of Expertise
Hospital for bariatric
surgery.
Stanley Rogers, MD, FACS, Associate Clinical Professor of Surgery and Co-Director of the UCSF Bariatric Surgery Center, and John Cello, MD, Professor of Medicine and Surgery, and Medical Director of Bariatric Surgery Center, recently led a multidisciplinary team in performing the first two of thirty procedures scheduled at the UCSF Medical Center. The investigational procedure, transoral gastroplasty, or "TOGA" for short, is being tested in a clinical trial. UCSF is one of nine U.S. trial sites. Drs. Rogers and Cello are principal investigators on the study.
"Blue Shield's Bariatric Quality Initiative has recognized California surgeons and hospitals for meeting high-quality standards in bariatric surgery. To qualify for this distinction, bariatric surgeons and hospitals had to demonstrate a commitment to quality by meeting a comprehensive set of volume, outcomes, process, and program criteria."